The development of DM is composed of several pathogenic processes including the autoimmune destruction of pancreatic cells (DM type 1) or abnormalities that result in resistance to insulin action (DM type 2), in both cases result in inefficient insulin activity in target tissues (Kesavulu et al., 2000). This evidence concerns the gene INS and diabetes mellitus.